ESR1 and triple-negative breast carcinoma: Two breast cancer cell lines were used for these assays: the non-invasive MCF-7 cells, which are ER+ breast cancer cells that were also used for the computational analysis, and the highly invasive Hs 578T cells, which are triple-negative breast cancer cells.